ROS Therapeutics ApS — Credit Rating and Financial Key Figures

ROS Therapeutics ApS (CVR number: 39507501) is a company from ROSKILDE. The company recorded a gross profit of -677.6 kDKK in 2023. The operating profit was -690.4 kDKK, while net earnings were -1152.4 kDKK. The profitability of the company measured by Return on Assets (ROA) was -9.1 %, which can be considered poor and Return on Equity (ROE) was -43.7 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -73.4 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. ROS Therapeutics ApS's liquidity measured by quick ratio was 8.4 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.